Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years - 75 Years|
- - Male or female, aged 18 to 75 years (inclusive) - Have a diagnosis of plaque type psoriasis for ≥ 6 months.
- - Must have chronic plaque type psoriasis of moderate severity.
- - All subjects must agree and commit to the use of a reliable contraceptive regimen.
- - Current diagnosis of forms of psoriasis other than chronic plaque type only.
- - Drug-induced psoriasis.
- - Other inflammatory skin disease that may confound the evaluation of plaque psoriasis.
- - Failed 2 or more systemic treatments for plaque psoriasis.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Ira ThorlaJose CardonaJennifer SoungJames KrellPaul YamauchiDelilah AlonsoAnnika SmithDeirdre MurrellLynda SpelmanSamantha Eisman|
|Principal Investigator Affiliation||Louisiana Dermatology AssociatesIndago Research and Health CenterSouthern California Dermatology, IncTotal Skin and Beauty Dermatology CenterClinical Science InstituteRevival Research InstituteWestmead HospitalPremier SpecialistVeracity Clinical Trials LtdSinclair Dermatology|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
|Countries||Australia, United States|
The disease, disorder, syndrome, illness, or injury that is being studied.
Experimental: Low dose group
39 subjects for low dose group. 26 subjects on KBL697, 13 subjects on placebo.
Experimental: High dose group
39 subjects for high dose group. 26 subjects on KBL697, 13 subjects on placebo.
Drug: - KBL697
1 capsule BID of KBL697 or Placebo
Drug: - KBL697
5 capsules BID of KBL697 or Placebo
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.